News
Signaling pathway evaluation of leading ATRi, PARPi and CDK7i cancer compounds targeting the DNA Damage Response using Causal Inference February 28 2023
Incubate Bio and Breakpoint Therapeutics announce collaboration to accelerate DNA Damage Response (DDR) drug discovery December 11 2023
Incubate Bio announces the first Generative AI engine for DNA Damage Repair target discovery – AskMaddy, December 7 2023
Incubate Bio announces new discovery pipeline of 70 potential oncology combination therapies, November 23 2023
Identification of Dasatinib as a potential combination therapy for AZD6738 in ovarian cancer, November 6 2023
QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma, October 24 2023
Launching service to address biotech’s #1 pain point – DATA FOR FUNDRAISING, October 12 2023
Cost-efficient expansion of key biological data to enhance the validation and value of therapeutic investment propositions, September 20 2023
Boosting biotech valuations with cost-efficient addition of key in silico evidence, September 8 2023
ALaSCAdb: Incubate Bio open sources characterized targets database for drug sensitivity and target discovery in Ovarian cancer, July 19 2023
Jiva.ai and Incubate Bio enter a Strategic Collaboration to Advance Personalized Medicine, April 3 2023
QV Bioelectronics and Incubate Bio enter a Strategic Collaboration to Accelerate the Treatment of Glioblastoma, March 27 2023